MedPath

The Effect of Oxycodone Hydrochloride on CRBD After TURBT Under General Anesthesia

Not Applicable
Not yet recruiting
Conditions
Effect of Drug
Adverse Effect of Opioids
Interventions
Registration Number
NCT05510986
Lead Sponsor
General Hospital of Ningxia Medical University
Brief Summary

The purpose of this study is to investigate the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia.

Detailed Description

Catheter-related bladder discomfort(CRBD) is a frequent complication after indwelling catheter under general anesthesia. The incidence of CRBD in patients undergoing Transurethral resection is as high as 66.7-91.2%.CRBD may lead some poor prognosis including postoperative restlessness, bleeding, and circulatory instability.therefore,how to reduce the incidence of CRBD is one of the urgent problems to be solved in clinic.

Oxycodone Hydrochloride is a strong opioid receptor agonist used in clinic at present. It has certain advantages in the regulation of visceral pain and can produce analgesic effect without causing restlessness, gastrointestinal motility inhibition and respiratory inhibition through stimulating the μ and κ opioid receptor simultaneously. However, the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia is still unknown. The purpose of this study is to explore whether Oxycodone Hydrochloride via intravenous injection could reduce the incidence of CRBD in patients undergoing transurethral resection of bladder tumor after general anesthesia and could not increase other complications during the recovery period of general anesthesiathe.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
196
Inclusion Criteria
  • More than 18 years old;
  • ASA I - III;
  • Plan to perform transurethral resection of bladder tumor under general anesthesia; (
  • Agree to participate in this study and sign the informed consent form.
Exclusion Criteria
  • Refuse to participate in this study;
  • Emergency surgery;
  • Catheter was indwelling before operation;
  • Taking opioids for a long time before operation;
  • Previous history of schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis;
  • Unable to communicate due to coma, severe dementia or language disorder before operation;
  • Critical condition (ASA grade ≥ IV before operation); Severe renal function damage (requiring renal replacement therapy); Severe liver function damage (child Pugh grade C); Acute stage of chronic obstructive pulmonary disease, severe asthma, severe pulmonary heart disease;
  • History of opioid allergy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oxycodone Hydrochloride groupOxycodone Hydrochloride groupDrugs
Fentanyl groupFentanyl groupDrugs
Primary Outcome Measures
NameTimeMethod
The incidence of catheter-related bladder discomfort1 hour

CRBD is symptoms vary among patients from burning sensation and pain in the suprapubic and penile areas to urinary urgency.

4 grades 0:No discomfort

1. Mild discomfort only reported upon questioning

2. Moderate discomfort, urge to pass urine reported by the patient without questioning

3. Severe discomfort, urge to pass urine accompanied by behavioral responses, such as flailing limbs, strong verbal responses, or attempt to pull out the catheter

Secondary Outcome Measures
NameTimeMethod
Degree of pain1 hour

NRS

the incidence of other complication1 hour

Respiratory depression, itching, shivering

The incidence of Nausea and vomiting1 hour

Nausea refers to patients who have gastrointestinal symptoms but do not spit out stomach contents. Vomiting means that the patient has gastrointestinal symptoms and vomits stomach contents

Degree of sedation1 hour

Ramsay evaluation

Trial Locations

Locations (1)

General Hospital of Ningxia Medical University

🇨🇳

Yinchuan, Ningxia, China

© Copyright 2025. All Rights Reserved by MedPath